Viewing StudyNCT00428142



Ignite Creation Date: 2024-05-05 @ 5:17 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00428142
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2007-01-25

Brief Title: Bortezomib Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkins Lymphoma
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Organization Data

Organization: Canadian Cancer Trials Group
Class: NETWORK
Study ID: LY13
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: NCIC Clinical Trials Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators